Non Dose Dense Chemotherapy For Metastatic Ewings Sarcoma- Outcomes And Prognostic Factors
نویسندگان
چکیده
منابع مشابه
Prognostic Factors for First-Line Chemotherapy Treated Metastatic Gastric Cancer
Despite the reduced incidence, gastric cancer is the second most common among cancer-related deaths in the word. In two-third of patients with gastric cancer are diagnosed with metastatic disease (Kamangar et al., 2006; Jemal et al., 2011). Without effective treatment, the median survival for metastatic disease is 3 to 5, however it may be extended 8-12 months with the platinum and taxane-conta...
متن کاملPrognostic factors in metastatic breast cancer treated with combination chemotherapy.
Six hundred nineteen patients with metastatic breast cancer, treated with a combination of 5-fluorouracil, Adriamycin, and cyclophosphamide, or close variations of this program, with or without immunotherapy were analyzed retrospectively to identify those host, tumor, or treatment characteristics that might be of prognostic importance in predicting response to chemotherapy and survival from ons...
متن کاملDose-Dense Chemotherapy in Metastatic Breast Cancer: Shortening the Time Interval for a Better Therapeutic Index.
Despite the advancement of targeted therapies in metastatic breast cancer, chemotherapy is still of pivotal importance. The concept of dose density is known to increase the efficacy of chemotherapy. In metastatic disease, preservation of the quality of life is equally important. Because of this, weekly regimens are a cornerstone in metastatic disease. Taxanes like paclitaxel or nab-paclitaxel a...
متن کاملOutcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma
BACKGROUND Pulmonary squamous cell carcinoma has not benefited from improvements in chemotherapy over the past decade, compared with non-squamous non-small-cell lung cancer. Nowadays, treatment strategies differ between squamous and non-squamous non-small-cell lung cancers. This study aimed to investigate the percentage of patients treated with first-, second-, or third-line chemotherapy and th...
متن کاملTreatment outcome and prognostic factors in non-metastatic esophageal carcinoma.
OBJECTIVE To investigate the therapeutic outcome and prognostic factors in patients with non-metastatic esophageal carcinoma. METHODS Between January 1989 and December 2003, 171 patients with non-metastatic esophageal carcinoma patients were retrospectively assessed in the Department of Radiation and Oncology, Institute of Oncology, Turkey. RESULTS The distribution of the stage at presentat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Hematology Oncology Journal
سال: 2019
ISSN: 2468-1245
DOI: 10.1016/j.phoj.2019.08.152